Low-penetrance susceptibility to breast cancer due to CHEK2<sup>*</sup>1100delC in noncarriers of BRCA1 or BRCA2 mutations.Published in:Nature Genetics, 2002, v. 31, n. 1, p. 55By:Meijers-Heijboer, Hanne;van den Ouweland, Ans;Klijn, Jan;Wasielewski, Marijke;de Snoo, Anja;Oldenburg, Rogier;Hollestelle, Antoinette;Houben, Mark;Crepin, Ellen;van Veghel-Plandsoen, Monique;Elstrodt, Fons;van Duijn, Cornelia;Bartels, Carina;Meijers, Carel;Schutte, Mieke;McGuffog, Lesley;Thompson, Deborah;Easton, Douglas F.;Sodha, NayantaPublication type:Article